[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-396424-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-396424-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nysdoh-bureau-of-tb-control-latent-tuberculosis-infection-ltbi-electronic-toolkit-updated-december-2024","NYSDOH Bureau of TB Control - Latent Tuberculosis Infection (LTBI) Electronic Toolkit - Updated December 2024","","Latent Tuberculosis Infection (LTBI) Electronic Toolkit provides guidance for assessing TB risk, deciding whether to test for TB infection, and managing subsequent steps based on results. It outlines a screening process for adults and children, emphasizing risk-factor evaluation, selective testing, and retesting when new risks emerge. The toolkit explains TB background, transmission, when to test (symptoms, exposures, immunosuppression, travel), and how LTBI can be confirmed through TST or IGRA while excluding active TB disease.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nysdoh-bureau-of-tb-control-latent-tuberculosis-infection-ltbi-electronic-toolkit-updated-december-2024/396424/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nysdoh-bureau-of-tb-control-latent-tuberculosis-infection-ltbi-electronic-toolkit-updated-december-2024/396424.png","ImageObject",300,407,{"name":42,"@type":43},"Jake","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-26",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"When should a patient be tested for TB infection for LTBI?","Question",{"text":63,"@type":64},"Test when the patient has TB symptoms, significant exposure to someone with TB, conditions or medications that weaken immunity, or history of birth/travel/living in higher-incidence countries for at least one month.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What screening principles guide risk assessment and LTBI testing decisions?",{"text":68,"@type":64},"Assess TB risk factors at least once as part of routine primary care, screen for new risks at later preventive visits, and retest if new risks are found since a prior negative test. Test only persons at risk to avoid unnecessary evaluations and treatment.",{"name":70,"@type":61,"acceptedAnswer":71},"What types of TB tests are used for LTBI, and how should results be interpreted?",{"text":72,"@type":64},"LTBI testing uses either the tuberculin skin test (TST/Mantoux, PPD) or blood test (IGRA/interferon-gamma release assay). Neither test distinguishes LTBI from active TB disease, and negative results do not exclude LTBI or active TB. A positive infection test requires evaluation for active TB using chest x-ray and other tests.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},396424,1790725386,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","NYSDOH BUREAU OF TB CONTROL  \nLatent Tuberculosis Infection (LTBI) Electronic Toolkit  \nUpdated December 2024  \nLTBI FLOW CHART Click any of the purple buttons to read more  \nStop.  \nNo further TB investigation or intervention needed.  \nNo  \nShould this patient be tested for TB infection?  \nYes  \nPositive TB Test  \nYes  \nActive TB is a Reportable Disease.  \nContact your local health department immediately.  \nDoes this patient have active TB disease?  \nNo  \nIs this patient a candidate for LTBI treatment?  \nLTBI Treatment Regimen Tables  \nClick the buttons below for:  \nICD-10 Codes  \nCommunication and Education Resources  \nContact your local health department’s TB program for consultation as needed  \nReferences  \nShould this Patient be Tested for TB Infection?  \nScreening Process  \nFollow these principles when assessing risk for TB disease and testing for LTBI:  \nAll adults and children should receive a TB risk factor assessment at least once as part of their routine primary care:  \n• Screen persons for new risk factors at subsequent preventive health visits.  \n• If new TB risk factors are identified since a person’s last negative TB test, retest.  \nTest only persons at risk:  \n• It can simplify treatment decisions. Testing low-risk persons can result in unnecessary evaluationsand treatment.  \n• Most persons with a risk factor and a positive TB test result should be treated for LTBI.  \nExamples of new risk factors include the following events and conditions:  \n• New close contact to a patient with infectious TB disease  \n• Residence or travel in a high-incidence country for an extended time (>1 month)  \n• New or anticipated immunosuppressive therapy  \nCertain people should be tested for TB infection because they are at higher risk for being infected with TB bacteria, including:  \n• People who have spent time with someone who has TB disease  \n• Travel to, or residence in a country with an elevated TB rate for at least 1 month. Includes any country other than the United States, Canada, Australia, New Zealand, or a country in western or northern Europe  \n• People who live or work in high-risk settings (for example: correctional facilities, and homeless shelters)  \n• Health-care workers who care for patients at increased risk for TB disease  \n• Infants, children, and adolescents exposed to adults who are at increased risk for latent tuberculosis infection or TB disease  \nCenters for Disease Control and Prevention (CDC), Latent Tuberculosis Infection: A Guide for Primary Health Care Providers, 2020.  \nCDC, Who Should Be Tested for TB Infection, 2024.  \nNational Society of Tuberculosis Clinicians, Testing and Treatment of Latent Tuberculosis Infection in the United States: Clinical Recommendations, 2024.  \nGroups at Risk for Developing TB  \nTB Background and Details  \nReturn to LTBI Flow Chart  \nShould this Patient be Tested for TB Infection?  \nBackground and Details  \nWhat is tuberculosis (TB)?  \n• TB is a disease caused by bacteria. It usually attacks the lungs but can affect any part of the body.  \n• People with latent TB infection (LTBI) can have TB bacteria in their body for years before getting sick with active TB disease and becoming contagious.  \n• Getting tested and treated for LTBI can prevent your patient from developing active TB disease in the future.  \nHow is TB spread?  \n• TB is spread from one person to another through the air. When a person sick with TB coughs, speaks, or sings, those around them can breathe in the TB bacteria and get infected.  \nWhen should the patient get tested for TB?  \n• If the patient has symptoms of TB (for example, coughing for 3 weeks or more or coughing up blood, heavy sweating at night, feeling very tired, fever or chills, loss of appetite, or unplanned weight loss) .  \n• If the patient has spent a lot of time around someone with TB.  \n• If the patient takes certain medications or has a medical condition, such as HIV or cancer, that can weaken the immune system.  \n• If the patient was born ","cbCaifS1qGWfoh7a","https://ap.wps.com/l/cbCaifS1qGWfoh7a","pdf",398717,32,"English","# LTBI Flow Chart\n## Screening Process and Risk Principles\n## TB Background and Details\n# Types of TB Tests and Which to Use\n## Recommendation for Type of Test in Adults\n## Recommendation for Type of Test in Children","[{\"question\":\"When should a patient be tested for TB infection for LTBI?\",\"answer\":\"Test when the patient has TB symptoms, significant exposure to someone with TB, conditions or medications that weaken immunity, or history of birth/travel/living in higher-incidence countries for at least one month.\"},{\"question\":\"What screening principles guide risk assessment and LTBI testing decisions?\",\"answer\":\"Assess TB risk factors at least once as part of routine primary care, screen for new risks at later preventive visits, and retest if new risks are found since a prior negative test. Test only persons at risk to avoid unnecessary evaluations and treatment.\"},{\"question\":\"What types of TB tests are used for LTBI, and how should results be interpreted?\",\"answer\":\"LTBI testing uses either the tuberculin skin test (TST/Mantoux, PPD) or blood test (IGRA/interferon-gamma release assay). Neither test distinguishes LTBI from active TB disease, and negative results do not exclude LTBI or active TB. A positive infection test requires evaluation for active TB using chest x-ray and other tests.\"}]","NYSDOH Bureau of TB Control - Latent Tuberculosis Infection (LTBI) Electronic Toolkit - Updated December 2024 | PDF",1790441176,81]